Cardiovascular Health And Risk Modification in Family Health Teams
Multi-CHARM
Multidisciplinary Cardiovascular Health And Risk Modification in Family Health Teams
1 other identifier
interventional
229
1 country
1
Brief Summary
Cardiovascular diseases remain the main cause of mortality in Canada. While effective interventions are available for reducing the risk of cardiovascular disease,there continue to be gaps between the potential reduction in risk that could be achieved by effectively managing these risk factors and levels of risk factor control currently in clinical practice. This study will evaluate the ability of a different model of risk factor care using other health providers assisting family doctors, along with information aids for patients and health professionals,to achieve better levels of cardiovascular risk factor control in adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Oct 2008
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2008
CompletedFirst Submitted
Initial submission to the registry
November 6, 2008
CompletedFirst Posted
Study publicly available on registry
November 7, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2009
CompletedApril 3, 2018
March 1, 2018
8 months
November 6, 2008
March 31, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
mean systolic blood pressure
6 months
Secondary Outcomes (1)
Proportion of adults with 3 cardiovascular risk factors under optimal control
6 months
Study Arms (2)
Multi-faceted Cardiovascular Decision Support
EXPERIMENTALRisk factor active surveillance, multi-disciplinary disease management and decision aid intervention
Control Usual Care
OTHERUsual care in a wait-list control arm that receives the experimental intervention after 6 months.
Interventions
Cardiovascular risk status assessment followed by active surveillance and physician review where risk factor control is suboptimal
Eligibility Criteria
You may qualify if:
- adults 50 to 80 years of age
- having attending a family medicine clinic for more than one year
You may not qualify if:
- not able to participate for one year
- not able to read English
- requires house calls
- nursing home resident
- cognitive impairment
- current chest pain or symptoms of active coronary heart disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Granovsky Gluskin Family Medicine Cwntre
Toronto, Ontario, M5T 3L9, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Warren J McIsaac, MD
Granovsky Gluskin Family Medicine Centre, Mount Sinai Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
November 6, 2008
First Posted
November 7, 2008
Study Start
October 1, 2008
Primary Completion
June 1, 2009
Study Completion
June 1, 2009
Last Updated
April 3, 2018
Record last verified: 2018-03
Data Sharing
- IPD Sharing
- Will not share